Contineum Therapeutics Inc. – Filings and Transcripts

NASDAQ: CTNM
Share price (4/9/26): $12.83
Market cap (4/9/26): $479 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Ownership Filter

Lorrain Daniel S.

Lorrain Daniel S.

Lorrain Daniel S.

Stengone Carmine N.

News Filter

Reports Fourth-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Announces Proposed $75.0 Million Public Offering

Other Events, Financial Statements or Exhibits

Reports Topline Data From Its Phase 2 Pipe-307 Vista Trial for the Treatment of Relapsing-Remitting Multiple Sclerosis

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

SEC STAFF LETTER